首页> 外国专利> Composition for enhancing transgene expression in eukaryotic cells and method for increased production of the target protein encoded by the transgene

Composition for enhancing transgene expression in eukaryotic cells and method for increased production of the target protein encoded by the transgene

机译:用于增强真核细胞中转基因表达的组合物和增加由转基因编码的靶蛋白的产量的方法

摘要

1. A composition for the intensive production of the target protein in eukaryotic cells, comprising a DNA vector with an insert of the target gene protein and the cellular receptor agonist class of receptors PRR - pattern recognition receptors, selected from the following agonists: TLR2 receptor agonists or TLR4 agonists or agonists TLR5 receptor, or TLR7 agonists, TLR8 or receptor agonists or TLR9 agonists or NOD1-receptor agonists or NOD2-receptor agonists, taken in optimal sootnosheniyah.2. A composition according to claim 1, characterized in that the TLR2 receptor agonist used lipoteichoic kislotu.3. A composition according to claim 1, characterized in that the TLR2 receptor agonist used lipopeptid.4. A composition according to claim 1, characterized in that the TLR4 receptor agonist used bacterial lipopolisaharid.5. A composition according to claim 1, characterized in that the TLR4 receptor agonist used acidic peptidoglycan having a molecular weight 1200-40000 kDa.6. A composition according to claim 1, characterized in that the TLR5 receptor agonist used flagellin.7. A composition according to claim 1, characterized in that as a TLR7 receptor agonist used imikvomod.8. A composition according to claim 1, characterized in that as a TLR8 receptor agonist used imikvomod.9. A composition according to claim 1, characterized in that as a TLR7 receptor agonist formulation used CL097, which is a derivative imidazohinolina.10. A composition according to claim 1, characterized in that as a TLR8 receptor agonist formulation used CL097, which is a derivative imidazohinolina.11. A composition according to claim 1, characterized in that the TLR9 receptor agonist used oligonukleo
机译:1.一种用于在真核细胞中大量生产靶蛋白的组合物,其包含具有靶基因蛋白插入物的DNA载体和选自以下激动剂的细胞受体激动剂类别的受体PRR-模式识别受体:TLR2受体激动剂或TLR4激动剂或TLR5受体激动剂,TLR7激动剂,TLR8或受体激动剂或TLR9激动剂或NOD1受体激动剂或NOD2受体激动剂。 2.根据权利要求1的组合物,其特征在于TLR2受体激动剂使用脂蛋白​​回声kislotu.3。 2.根据权利要求1的组合物,其特征在于TLR2受体激动剂使用脂肽4。 2.根据权利要求1的组合物,其特征在于TLR4受体激动剂使用了细菌脂质脂。 2.根据权利要求1的组合物,其特征在于TLR4受体激动剂使用了分子量为1200-40000kDa.6的酸性肽聚糖。 2.根据权利要求1的组合物,其特征在于TLR5受体激动剂使用鞭毛蛋白。 2.根据权利要求1的组合物,其特征在于使用imikvomod.8作为TLR7受体激动剂。 2.根据权利要求1的组合物,其特征在于使用imikvomod.9作为TLR8受体激动剂。 2.根据权利要求1的组合物,其特征在于,使用CL097作为TLR7受体激动剂制剂,其为咪唑啉代衍生物10。 2.根据权利要求1的组合物,其特征在于,使用CL097作为TLR8受体激动剂制剂,其为咪唑啉衍生物11。 2.根据权利要求1所述的组合物,其特征在于,所述TLR9受体激动剂使用了寡核糖体

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号